SEC Comment Letter 0000000000-23-004719 to Renalytix plc (RNLX, RTNXF) (CIK 0001811115) (RENXF)
Renalytix plc (RNLX, RTNXF) (CIK 0001811115)
Date: May 5, 2023 · CIK: 0001811115 · Accession: 0000000000-23-004719
AI Filing Summary & Sentiment
File numbers found in text: 333-271579
Letter
United States securities and exchange commission logo May 5, 2023 James McCullough Chief Executive Officer Renalytix plc Finsgate 5-7 Cranwood Street London EC1V 9EE United Kingdom Re:Renalytix plc Registration Statement on Form F-3 Filed on May 2, 2023 File No. 333-271579 Dear James McCullough: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Katie Kazem, Esq.
Show Raw Text
United States securities and exchange commission logo
May 5, 2023
James McCullough
Chief Executive Officer
Renalytix plc
Finsgate
5-7 Cranwood Street
London EC1V 9EE
United Kingdom
Re:Renalytix plc
Registration Statement on Form F-3
Filed on May 2, 2023
File No. 333-271579
Dear James McCullough:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Katie Kazem, Esq.